S&P Futures
3,606.00 +4.50 (+0.12%) Dow Futures
28,881.00 +80.00 (+0.28%) Nasdaq Futures
11,017.75 -17.75 (-0.16%) Russell 2000 Futures
1,673.70 +3.90 (+0.23%) Crude Oil
81.82 +2.33 (+2.93%) Gold
1,672.30 +0.30 (+0.02%)
Tetra Bio-Pharma Inc. (TBPMF)
Chart Events
Performance Outlook
| Previous Close | 0.0275 |
| Open | 0.0274 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0254 - 0.0290 |
| 52 Week Range | 0.0216 - 0.2267 |
| Volume | |
| Avg. Volume | 88,271 |
| Market Cap | 10.835M |
| Beta (5Y Monthly) | 1.91 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0840 |
| Earnings Date | Jul 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for TBPMF
Related Research
- TETRA BIO PHARMA INCDaily Spotlight: Alternative Investments Weak as WellAlternative investments are supposed to hedge against stock and bond market weakness. At least that's what the textbooks say. The most popular alternatives include Gold, Real Estate, Commodities, and, recently, Bitcoin. Only one of the alternatives (Commodities) has provided a respite for investors in 2022, with returns of 7% on the commodity benchmark ETF DBC. Gold isn't bad, down 5%. Real Estate held up early in the year -- but as interest rates have risen, the benchmark ETF IYR has fallen sharply and is down 21% YTD. Each of these is better than Crypto, of course. The approximately $1.0 trillion Cryptocurrency market has tumbled in recent months from $3.7 trillion amid a high level of volatility and a risk-off move in financial markets. Year-to-date, Bitcoin is down about 50%. In theory, consumers, investors, and traders are all attracted to Bitcoin. Given high inflation, we think Commodities will remain in demand and are the best-positioned alternative. In our view, Commodities should constitute up to 3%-5% of portfolios, with Copper and Paper/Corrugated Packaging having the most exposure due to positive long-term secular trends behind e-vehicles and e-commerce. We still think it is early to be adding volatile Bitcoin-related securities to our model portfolios at this time. We will reconsider Cryptocurrencies once the sector approaches total market capitalization of $5 trillion, or the regulatory outlook becomes clearer.RatingFair ValueEconomic Moat5 days agoArgus Research
- CNW Group
Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development, announced today that the Company has revised the terms of its previously announced financing arrangement (the "Financing") with Global Corporate Finance Opportunities 16 (the "Investor"), an investment vehicle advised by Alpha Blue Ocean ("ABO"), and has closed the first tranche of the Financing on such revised terms, the whole pursuant to the term
- PR Newswire
Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development announced today they signed an agreement with Cellvera Global Holdings LLC ("Cellvera"), for the co-development of ARDS-003 as a combination product, with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug.
